Substituted benzimidazoles as inhibitors of transforming growth factor-β kinase
US11767298B2 · kind B2 · utility
0Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2021 |
| Grant date | Sep 26, 2023 |
| Priority date | — |
| Expiry date | Aug 5, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides inhibitors of TAK1 having formula (I) and methods of using such compounds to treat various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.